Hepatitis C Current Events | Hepatitis C News | 3
|
| Page
3 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
HEPATITIS B INFECTION AT AN ALTERNATIVE THERAPY CENTRE
A study in this week's issue of THE LANCET emphasises the continuing risk of transmission of bloodborne viruses in health-care settings where skin-piercing procedures are used. In more developed countries, such as the USA and UK, the prevalence of hepatitis B virus (HBV) infection is low. George Webster and colleagues describe the epidemiology of... view more... (2000-07-26)
Protecting HIV patients from Hepatitis B virus
Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other. view more (2007-07-18)
Mount Sinai finds those with more difficult to treat forms of HCV are half as likely to get treated
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. view more (2009-11-10)
Mathematical model identifies genes which battle hepatitis C
Joint research by Dr. Leonid Brodsky, of the Institute of Evolution of the University of Haifa, and Dr. Milton Taylor, of Indiana University, led to the discovery of a mathematical method which can identify which genes in our bodies conduct the battle against the various viruses that attack us. view more (2007-07-20)
How to select anti-hepatitis B virus agents for drug-resistance patients?
HBV infection may lead to acute liver disease, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. Over 350 million people worldwide are estimated to be infected chronically by HBV and are therefore at risk of liver failure, cirrhosis, or hepatocellular carcinoma. view more (2008-09-25)
How to increase the chances of remaining virus free Pakistani patients with HCV?
Hepatitis C is a health care problem all over the world, with 130 million patients infected the world over. The treatment is expensive and has variable results according to the genotype of the infecting virus. view more (2008-05-21)
Cure for hepatitis C announced by VCU researcher
The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today. view more (2007-05-22)
New hope for Hepatitis C research
The mystery surrounding Hepatitis C, a disease that affects millions of people worldwide, is one step closer to being solved. view more (2006-08-11)
Interferon does not slow or stop hepatitis C from worsening, study finds
Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven't responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found. view more (2007-11-09)
Making headway against hepatitis C: SLU study shows new drug combo effective in non-responders
Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies. view more (2006-10-30)
Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail." view more (2008-07-25)
Liver disease breakthrough by new University company
Ref: 03/49 14 April 2003 A new spin-out company from the University of Southampton aims to revolutionise the diagnosis and treatment of hepatitis C and save the NHS millions of pounds. HepCgen has been founded by liver disease specialist Dr William Rosenberg, who has worked and researched in this... view more... (2003-04-14)
Current hepatitis C treatments work equally well, UT Southwestern and national researchers report
The three treatment combinations for clearing the most common form of the hepatitis C virus work equally well with similar side effects, UT Southwestern Medical Center researchers and their colleagues in 13 other institutions have found. view more (2009-08-07)
Mutation protects from HIV - and increases risk of hepatitis C
More than 40 million people worldwide are infected with the human immunodeficiency virus HIV. In Africa alone this incurable immune deficiency caused more than two million deaths last year. Yet some people are resistant to infection: the reason for this is a mutation in their DNA which prevents the HIV virus from invading certain immune cells and... view more... (2002-07-17)
New Strategy for Inhibiting Virus Replication
Viruses need living cells for replication and production of virus progeny. Thus far, antiviral therapy primarily targets viral factors but often induces therapy resistance. New improved therapies attempt to targets cellular factors that are essential for viral replication. view more (2009-08-17)
Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C?
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others. view more (2009-08-27)
Hepatitis B patients' understanding of infection and treatment deficient
Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem. view more (2007-05-29)
High hepatitis B infection rate found among NYC's Asian American community
Approximately 15% of Asians living in New York City are chronically infected with hepatitis B virus, according to a new study by New York University School of Medicine researchers and their colleagues. view more (2006-05-12)
Hepatitis C at epidemic levels among young injectors in London
Levels of hepatitis C among young injecting drug users across London are reaching epidemic levels report researchers from Imperial College London, the Health Protection Agency and the London School of Hygiene and Tropical Medicine. view more (2004-11-10)
Researchers map infectious hepatitis B virus
Using electron cryomicroscopy and computer image analysis, the scientists visualized two intermediate forms of the virus that exist within infected cells. In addition, they were able to determine a three-dimensional map by analysis of infectious hepatitis B virus isolated from patient blood samples. view more (2006-06-26)
|
|
| Page
3 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
|
